Home
clear space
Press Releases Line Publications Line Presentations Line Posters Line

Presentations

William E. Pierceall, Steven L. Warner, Ryan J. Lena, Camille Doykan, Noel Blake, Michael Elashoff, Daniel D. Von Hoff, David J. Bearss, Michael H. Cardone, Michael Grever, Mark C. Lanasa, John C. Byrd, Amy J. Johnson Bcl-xL dependence predicts response to alvocidib in chronic lymphocytic leukemia patients. Proceedings of AACR Annual Meeting, 2014 San Diego, CA.
Bearss, David J.; Bahr, Brigham; Call, Lee; Stephans, Bret J.; Warner, Steven L. Novel series of metabolic activators of PKM2 alter oncogene-meditated changes in tumor cell growth and metabolism Abstracts of Papers, 246th ACS National Meeting & Exposition, Indianapolis, IN, United States, September 8-12, 2013
Robert Cardnell, Lixia Diao, Jing Wang, David Bearss, Steven Warner, You Hong Fan, Uma Giri, Michael D. Story, John N. Weinstein, Kevin R. Coombes, Michelle D. Williams, The Cancer Genome Atlas Reseach Network, Ignacio Ivan Wistuba, Gordon B. Mills, Jeffrey Myers, William Nassib William, K. Kian Ang, John Heymach, Lauren Averett Byers, An epithelial-mesenchymal transition (EMT) gene signature to predict resistance to EGFR inhibition and AXL identification as a therapeutic target in head and neck squamous cell carcinoma. J Clin Oncol 31, (suppl; abstr 6011) 2013
Albertson, DJ; Bearss, JJ; Bearss, DJ; Tripp, S; Liu, T Proviral Integration Site Moloney Murine Leukemia Virus (PIM) Expression in Urothelial Carcinoma LABORATORY INVESTIGATION Volume: 93 Supplement: 1 Pages: 191A-192A 2013
Bret J. Stephens, Alexis Mollard, Lingyao Meng, David J. Bearss, Steven L. Warner. TP-0413 is a dual-specific inhibitor against Jak2 and Alk2 with therapeutic potential for treating anemia of chronic disease. Proceedings of AACR Annual Meeting, 2013 Washington DC.
Mary Faris, Uriel M. Malyankar, Victor Tam, Colleen Schweitzer, Diljeet Joea, Alexis Mollard, Bret Stephens, Steven L. Warner, David J. Bearss, Qingping Zeng. Small molecule inhibitor of the BTK pathway disrupts BCR signaling and demonstrates antitumor efficacy in a xenograft model Proceedings of AACR Annual Meeting, 2013 Washington DC.
Jessica Flory, Rachel Brog, Ling Yao Meng, Lee Call, Hariprasad Vankayalapati, Guido Tricot, Fenghuang Zhan, David J. Bearss Overexpression of Nek2 promotes bortezomib resistance in multiple myeloma cells Proceedings of AACR Annual Meeting, 2013 Washington DC.
Brian Walker, Sorna Venkataswamy, Steven Warner, Lee Call, Hariprasad Vankayalapati, Sunil Sharma, David J. Bearss. Mechanisms of sensitivity to treatment with the PDK1 inhibitors HCI-1680 and HCI-1708 Proceedings of AACR Annual Meeting, 2013 Washington DC.
Brigham L. Bahr, Jenny Stevens, Spencer Squire, Christopher Moreno, Lee T. Call, Bret J. Stephens, Alexis Mollard, Steven L. Warner, David J. Bearss A novel series of metabolic activators of PKM2 alter oncogene-meditated changes in tumor cell metabolism Proceedings of AACR Annual Meeting, 2013 Washington DC.
Kent J. Carpenter, Rachel Brog, Christopher Moreno, Daniel J. Albertson, Jared J. Bearss, Ting Liu, Steven Warner, David J. Bearss, Small molecule inhibitors of PIM kinases as potential treatments for urothelial carcinomas Proceedings of AACR Annual Meeting, 2013 Washington DC.
Malia Anderson, Alex Ober, Alexis Mollard, Lee Call, Jared J. Bearss, Hariprasad Vankayalapati, Sunil Sharma, Steven Warner, David J. Bearss, Inhibition of the tyrosine kinase receptor Axl blocks cell invasion and promotes apoptosis in pancreatic cancer cells. Proceedings of AACR Annual Meeting, 2013 Washington DC.
Colman H, Oddou MP, Mollard A, Call LT, Vakayalapati H, Warner SL, Sharma S, Bearss DJ. A MULTI-TARGETED KINASE INHIBITOR (HCI-2084) POTENTLY INHIBITS THE AURORA, AXL, AND STAT3 PATHWAYS AND CAUSES CELL CYCLE ARREST AND APOPTOSIS IN GBM STEM-LIKE CELLS. NEURO-ONCOLOGY 14: 34-35, 2012
Lingyao Meng, Steven L. Warner, Alexis Mollard, Hariprasad Vankayalapati, Sunil Sharma, David J. Bearss. Inhibition of Nek2 by novel small molecules affects proteasome activity. Proceedings of AACR Annual Meeting, 2012.
Anupam Verma, J. Kimble Frazer, Alesia Trakhimets, William Heaton, Jared Bearss, Steven Warner, David Bearss, and Sunil Sharma. A Novel Dual AXL/Mertk and Aurora Kinase Inhibitor Active Against T Cell Acute Lymphoblastic Leukemia. American Society of Hematology Annual Meeting, San Diego, CA 2011.
Sunil Sharma, Sorna Venkataswamy, Steven L. Warner, Lee T. Call, David J. Bearss, Hariprasad Vankayalapati. Fragment-based design, synthesis and biological evaluation of a series of novel PDK1 inhibitors. Proceedings of AACR Annual Meeting, 2011.
Lee T. Call, Alexis Mollard, Mark L. Wade, Jared J. Bearss, Mei Yang, Anupam Verma, Hariprasad Vankayalapati, Marc D.H. Hansen, David J. Bearss, Sunil Sharma, Steven L. Warner. Targeting the Axl tyrosine kinase receptor in pancreatic cancer. Proceedings of AACR Annual Meeting, 2011.
Alexis Mollard, Steven L. Warner, Lee Call, Mark Wade, Jared Bearss, Anupam Verma, Mei Yang, Sunil Sharma, David J. Bearss, Hariprasad Vankayalapati. Homology structure-based design, synthesis and biological evaluation of a series of novel Axl and Mer kinase inhibitors. Proceedings of AACR Annual Meeting, 2011.


clear space